IFNβ bioavailability in MS patients treated with three different IFNβ preparations:: A 96-hour time-course study

被引：0
|
作者：
Milano, E
Gilli, F
Melis, F
Sala, A
Malucchi, S
Bottero, R
Giordana, MT
Bertolotto, A
机构：
来源：
NEUROLOGY | 2002年 / 58卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A72 / A73
页数：2
相关论文
共 16 条
  • [1] RELATIVE FREQUENCY OF NONNEUTRALIZING ANTIBODIES TO INTERFERON (IFN) IN HEPATITIS PATIENTS TREATED WITH DIFFERENT IFN-ALPHA PREPARATIONS
    ANTONELLI, G
    CURRENTI, M
    TURRIZIANI, O
    RIVA, E
    DIANZANI, F
    JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03): : 593 - 594
  • [2] Neutralizing and binding antibodies to IFN-β:: Relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-β preparations
    Scagnolari, C
    Bellomi, F
    Turriziani, O
    Bagnato, F
    Tomassini, V
    Lavolpe, V
    Ruggieri, M
    Bruschi, F
    Meucci, G
    Dicuonzo, G
    Antonelli, G
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2002, 22 (02): : 207 - 213
  • [3] Longitudinal time-domain optic coherence study of retinal nerve fiber layer of IFNβ-treated and untreated MS patients
    Pul, R.
    Sadat, M.
    Morbiducci, F.
    Skripuletz, T.
    Pul, Ue
    Brockmann, D.
    Suehs, K-W
    Stangel, M.
    Trebst, C.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 365 - 365
  • [4] MxA protein in MS patients treated with different doses of IFN beta-1b (the OPTIMS Study): Correlation with treatment response, IFN beta dose, and neutralizing antibodies (NAb) occurrence
    Ricci, A
    Giordano, L
    Cucci, MA
    Clerico, M
    Verdun, E
    Barbero, P
    Pipieri, A
    Ferrero, B
    Festa, E
    Durelli, L
    Gonzaga, OSL
    NEUROLOGY, 2005, 64 (06) : A387 - A387
  • [5] Transmigration of PBMNCs from β-IFN-lb-treated MS patients:: a one-year longitudinal study
    Gelati, M
    Corsini, E
    Dufour, A
    Zaffaroni, M
    Milanese, C
    La Mantia, L
    Massa, G
    Salmaggi, A
    AUTOIMMUNITY, 2001, 33 (04) : 275 - 283
  • [6] Monitoring IFN beta treated MS patients using multimodal MRI: one year follow-up (REPROMMS study)
    Tourbah, A
    Charles, R
    Dormont, D
    Payan, C
    Stankoff, B
    Lacomblez, L
    Fontaine, B
    Chiras, J
    Lyon-Caen, O
    MULTIPLE SCLEROSIS, 2005, 11 : S56 - S57
  • [7] Study in CHC patients comparing three different combination therapies with interferon a-2b (IFN) and ribavirin (Rebetol):: Weekly PEG-IFN (Peg- intron) versus daily IFN (Intron A pen) versus standard regimen of IFN (Intron A pen)
    Horsmans, Y
    Colle, I
    Van Vlierberghe, H
    Langlet, P
    Adler, M
    Brenard, R
    Micheilsen, P
    Bourgeois, N
    Lefèbvre, V
    Henrion, J
    De Koninck, X
    Bruckers, L
    GASTROENTEROLOGY, 2003, 124 (04) : A768 - A768
  • [8] Time-Course Changes in Bone Metabolism Markers and Density in Patients with Osteoporosis Treated with Romosozumab: A Multicenter Retrospective Study
    Inage, Kazuhide
    Orita, Sumihisa
    Eguchi, Yawara
    Shiga, Yasuhiro
    Koda, Masao
    Aoki, Yasuchika
    Kotani, Toshiaki
    Akazawa, Tsutomu
    Furuya, Takeo
    Nakamura, Junichi
    Takahashi, Hiroshi
    Suzuki-Narita, Miyako
    Maki, Satoshi
    Hagiwara, Shigeo
    Inoue, Masahiro
    Norimoto, Masaki
    Kinoshita, Hideyuki
    Sato, Takashi
    Sato, Masashi
    Enomoto, Keigo
    Takaoka, Hiromitsu
    Mizuki, Norichika
    Hozumi, Takashi
    Tsuchiya, Ryuto
    Kim, Geundong
    Otagiri, Takuma
    Mukaihata, Tomohito
    Hishiya, Takahisa
    Ohtori, Seiji
    YONSEI MEDICAL JOURNAL, 2021, 62 (09) : 829 - 835
  • [9] Employment status and health-related quality of life of MS patients in a never treated and only ever treated with IFNβ-1a sc cohorts: an exploratory study
    Hum, S.
    Bigras, C.
    Roger, E.
    Duquette, P.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 677 - 677
  • [10] Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients
    Pul, Refik
    Saadat, Mehdi
    Morbiducci, Franco
    Skripuletz, Thomas
    Pul, Uensal
    Brockmann, Dorothee
    Suehs, Kurt-Wolfram
    Schwenkenbecher, Philipp
    Kahl, Kai Guenter
    Pars, Kaweh
    Stangel, Martin
    Trebst, Corinna
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (01) : 190 - 200
12